Skip to content
profile_picture

Affiliation

University Hospitals of Leuven

Country

Belgium

1. Current Status, Position

Mrs Barbara Deleenheer is currently a clinical pharmacist at the paediatric oncology and haematology ward at the University Hospitals of Leuven.

2. Education

Barbara Deleenheer studied Pharmacy at the University of Leuven and became a licensed pharmacist in 2011. In 2013 she obtained the degree of hospital pharmacist and in 2014 the degree of clinical pharmacist. In 2016, she worked as a clinical pharmacist on the gastro-enterology ward at the University Hospital of Cambridge in the UK.

3. Research Area

Barbara Deleenheer’s research currently focuses on various topics in the paediatric patient population (health literacy, pharmacokinetics,…).

4. Conflict of interest: none

×

Join us in Prague at the special rate of
350 Euro*(+ 21% Czech VAT)
to promote
WORLD PHARMACIST DAY 2025!

Secure your spot (only 45 seats available!)

*instead of 400 Euro – Offer available from 25/09 at 00h01 to 30/09 at 23h59 CET

×

Join us in Prague for

the 2nd edition of BOOST!

Secure your spot (limited seats available!)

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy — the shortage of medicine and medical devices.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.